WHO ICTRP trial
MULTICENTER, RANDOMIZED, DOUBLE-BLIND STUDY TO ASSESS THE SAFETY OF THE…
PER-089-04 · Registro Peruano de Ensayos Clínicos (REPEC) · Not Recruiting
Key facts
| Trial ID | PER-089-04 |
|---|---|
| Public title | MULTICENTER, RANDOMIZED, DOUBLE-BLIND STUDY TO ASSESS THE SAFETY OF THE MONOTHERAPY WITH MK-0431 IN PATIENTS WITH DIABETES MELLITUS TYPE 2 AND CHRONIC RENAL INSUFICIENCY THAT HAVE AN INAPPROPRIATE GLUCEMIC CONTROL. |
| Scientific title | MULTICENTER, RANDOMIZED, DOUBLE-BLIND STUDY TO ASSESS THE SAFETY OF THE MONOTHERAPY WITH MK-0431 IN PATIENTS WITH DIABETES MELLITUS TYPE 2 AND CHRONIC RENAL INSUFICIENCY THAT HAVE AN INAPPROPRIATE GLUCEMIC CONTROL. |
| Primary sponsor | MERCK SHARP & DOHME PERU S.R.L., |
| Registry | Registro Peruano de Ensayos Clínicos (REPEC) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | III |
| Conditions | -E119 Non-insulin-dependent diabetes mellitus, without complications Non-insulin-dependent diabetes mellitus, without complications;E119;Non-insulin-dependent diabetes mellitus, without complications |
| Interventions | Group name:Group 1 Type of group;1 N° of participants:60 Intervention(s) description:2 tablets of a dose of 25 mg of MK-0431 for 12 weeks Group name:Group 2 Type of group;2 N° of participants:30 Intervention(s) description:Placebo orally… |
| Registration date | Jan 18, 2005 |
| Target size | 12 |
| Registry page | ins.gob.pe |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: